• 1. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

Introduction to 2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetic acid (CAS No. 70598-03-7) and Its Emerging Applications in Chemical Biology

2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetic acid, identified by the chemical identifier CAS No. 70598-03-7, is a heterocyclic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential biological activities. The compound belongs to the pyrazole class, which is well-documented for its versatility in medicinal chemistry. Specifically, the presence of a trimethyl-substituted pyrazole core enhances its pharmacological profile, making it a valuable scaffold for drug discovery efforts.

The molecular structure of 2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetic acid features a pyrazole ring substituted with three methyl groups at the 1, 3, and 5 positions, coupled with an acetic acid moiety at the 4-position. This arrangement imparts distinct electronic and steric properties that influence its interactions with biological targets. The compound’s solubility profile and metabolic stability have been subjects of extensive investigation, as these factors are critical for its suitability in therapeutic applications.

In recent years, there has been a surge in research focused on developing novel small molecules that modulate biological pathways associated with inflammation, cancer, and neurodegenerative diseases. The trimethyl-substituted pyrazole moiety in 2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetic acid has been identified as a key pharmacophore that can interact with various enzymes and receptors. For instance, studies have demonstrated its potential as an inhibitor of cyclooxygenase (COX) enzymes, which play a pivotal role in the production of prostaglandins involved in pain and inflammation.

One of the most compelling aspects of 2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetic acid is its ability to serve as a precursor for more complex derivatives. Researchers have leveraged this compound to synthesize analogs with enhanced bioavailability and targeted activity. For example, modifications at the acetic acid moiety have led to the development of compounds with improved binding affinity to specific protein targets. These derivatives are being explored in preclinical studies for their potential therapeutic efficacy.

The compound’s relevance extends beyond its role as an intermediate in drug synthesis. It has also been investigated for its antimicrobial properties. The unique structural features of trimethyl-substituted pyrazole compounds contribute to their ability to disrupt bacterial cell wall synthesis or interfere with essential metabolic pathways. Preliminary studies have shown promising results when tested against multidrug-resistant strains of bacteria, highlighting the compound’s potential as an alternative therapeutic agent.

Advances in computational chemistry have further accelerated the discovery of novel applications for 2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetic acid. Molecular docking simulations have been employed to predict its interactions with various biological targets, including kinases and transcription factors implicated in cancer progression. These virtual screening approaches have identified promising leads that are being validated through experimental studies.

The synthesis of 2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetic acid has also seen significant advancements due to innovations in synthetic methodologies. Catalytic processes have been developed to improve yield and purity while minimizing environmental impact. Such green chemistry approaches align with the growing emphasis on sustainable practices in pharmaceutical manufacturing.

Future directions in research on 2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetic acid include exploring its role in modulating immune responses. The compound’s ability to interact with immune cells and cytokine pathways suggests potential applications in immunotherapy. Additionally, its structural similarity to known bioactive molecules makes it a valuable candidate for structure-based drug design efforts aimed at developing next-generation therapeutics.

In conclusion,2-(1,3,5 Trimethyl 1H Pyrazol 4 yl acetic acid (CAS No. 70598 03 7) represents a promising compound with diverse applications in chemical biology and pharmaceutical research. Its unique structural features and biological activities make it a cornerstone in the development of novel drugs targeting various diseases. As research continues to uncover new insights into its mechanisms of action,trimethyl-substituted pyrazole derivatives will likely remain at the forefront of medicinal chemistry innovation.

• 956352-96-8(3-(1,3,5-Trimethyl-1H-pyrazol-4-yl)propanoic Acid)
• 1007462-48-7(2-(trimethyl-1H-pyrazol-4-yl)ethan-1-ol)
• 1269087-62-8(3-(1,3,5-trimethyl-1H-pyrazol-4-yl)propanoic acid hydrochloride)
• 1221724-52-2(2-1-(Difluoromethyl)-3,5-dimethyl-1H-pyrazol-4-ylacetic Acid)
• 1258651-44-3(2-(3,5-diethyl-1-methyl-1H-pyrazol-4-yl)acetic acid)
• 1082065-81-3(2-(trimethyl-1H-pyrazol-4-yl)acetaldehyde)
• 1177342-49-2(2-(1,3-dimethyl-1H-pyrazol-4-yl)acetic acid)
• 1007460-61-8(2-(trimethyl-1H-pyrazol-4-yl)propanoic acid)
• 1006446-62-3(3-(1,5-dimethyl-1H-pyrazol-4-yl)propanoic acid)
• 956935-28-7(2-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid)